Skip to main content
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.09
+0.09 (1.50%)
Mar 28, 2025, 4:00 PM EST

Knight Therapeutics Revenue

In the year 2024, Knight Therapeutics had annual revenue of 371.30M CAD with 13.13% growth. Knight Therapeutics had revenue of 96.86M in the quarter ending December 31, 2024, with 30.55% growth.

Revenue
371.30M
Revenue Growth
+13.13%
P/S Ratio
1.66
Revenue / Employee
498.39K
Employees
725
Market Cap
607.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Green Thumb Industries 1.64B
dentalcorp Holdings 1.55B
Sienna Senior Living 893.16M
WELL Health Technologies 957.69M
Extendicare 1.47B
Curaleaf Holdings 1.93B
Trulieve Cannabis 1.71B
Cronos Group 169.23M
Revenue Rankings

Knight Therapeutics News

More News